WO2004009003A1 - 生体温熱治療装置 - Google Patents
生体温熱治療装置 Download PDFInfo
- Publication number
- WO2004009003A1 WO2004009003A1 PCT/JP2002/007390 JP0207390W WO2004009003A1 WO 2004009003 A1 WO2004009003 A1 WO 2004009003A1 JP 0207390 W JP0207390 W JP 0207390W WO 2004009003 A1 WO2004009003 A1 WO 2004009003A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- temperature
- living body
- liquid
- minutes
- degrees celsius
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/0053—Cabins, rooms, chairs or units for treatment with a hot or cold circulating fluid
Definitions
- the present invention relates to a thermal treatment device, in particular, c background art relating thermal treatment device intended for the 'biological
- thermal treatment devices have been intended to locally treat a specific part of the human body using radio frequency or radiation.
- the conventional thermal treatment device as described above treats a specific part of the human body locally.For example, if cancer cells metastasize to other parts, the therapeutic effect cannot be obtained. There was a point.
- Japanese Patent Application Laid-Open Publication No. 2001-2999798 aims to treat almost the entire body of a human body by hyperthermia.
- a hyperthermia device intended to obtain an effect is disclosed. Disclosure of the invention
- thermotherapy device which can store a living body and can be filled with a liquid whose temperature can be controlled, an anesthesia unit for performing anesthesia on the living body stored in the living body storage unit, A liquid supply unit for supplying the living body to the liquid and supplying the liquid into the living body storage unit. It is a biological thermotherapy device.
- the present invention is a living body hyperthermia treatment device having a liquid temperature control means while having the above-mentioned components of the living body hyperthermia treatment apparatus.
- the body temperature of the living body is guided to the target temperature for treatment by controlling the liquid filled in the living body storage unit by the liquid temperature control means based on the numerical value according to the present invention, and the cancer cell is contained in the living body.
- the effect of treatment such as death of stomach can be obtained.
- Figure 1 is an example of a conceptual diagram.
- FIG. 2 is an example of a functional block diagram of the first embodiment.
- FIG. 4 is an example of a table according to the second embodiment.
- FIG. 5 is an example of a table according to the second embodiment.
- FIG. 6 is an example of a functional block diagram according to the fourth embodiment.
- FIG. 7 is an example of a table according to the fourth embodiment.
- FIG. 8 is an example of a table according to the fourth embodiment.
- FIG. 9 is an example of a table according to the fourth embodiment.
- FIG. 10 is an example of a table according to the fourth embodiment.
- FIG. 11 is an example of a schematic diagram showing the configuration of the fourth embodiment.
- FIG. 12 is an example of a schematic diagram showing the configuration of the fourth embodiment.
- FIG. 13 is an example of a schematic diagram showing the entire configuration of the fourth embodiment.
- Embodiment 1 of the present invention mainly corresponds to claims 1 and 2 and the like.
- Embodiment 2 of the present invention mainly corresponds to claims 3 to 6 and the like.
- Embodiment 3 of the present invention mainly corresponds to claims 7 to 11 and the like.
- Embodiment 4 of the present invention mainly corresponds to claims 12 to 14 and the like.
- the living body thermal therapy apparatus stores a living body in a living body storage unit.
- the living body container is filled with a liquid whose temperature can be controlled, and the living body is immersed in the liquid.
- the liquid supply unit included in the living body thermotherapy device raises the temperature of the liquid filled in the living body storage unit by liquid temperature control means, thereby raising the temperature of the living body immersed in the liquid to a target temperature.
- the living body can be maintained at the target temperature for a predetermined time.
- the target temperature is the temperature required to obtain the effect of the treatment.
- the predetermined time is a time necessary for obtaining the effect of the treatment.
- FIG. 1 is an example of a conceptual diagram illustrating blood components.
- Blood consists of plasma and cellular components.
- the cellular component consists of red blood cells, platelets, and white blood cells.
- Leukocytes consist of granulocytes, macrophages and lymphocytes.
- Lymphocytes consist of B lymphocytes, NK cells, T lymphocytes and other cells.
- T lymphocytes consist of suppressor T cells, killer T cells, helper T cells, and other T cells. It is CD8 that suppressor T cells and killer T cells are exposed.
- CD4 and CD8 are markers. What is detected in the blood test is a marker, and each T cell is measured by the marker.
- Both killer and helper T cells are a subset of the most evolved cells of the immune system and originate from bone marrow blood stem cells. Among them, progenitor cells that become lymphocytes undergo a negative selection for 3-4 days in the thymus, and only a few percent survive. During this time, T lymphocytes that have CD4 as a protein, which is a functional cell surface marker, are cleared of helper T cells (CD4 + positive T cells). And is supplied to the bloodstream. T lymphocytes with CD8 as a marker protein are becomes T cells (CD 8 + cytotoxic cells) and is supplied to the bloodstream.
- Helper T cells use a TCR, which is a T cell receptor on the cell surface and has specificity, such as an antibody that recognizes foreign proteins, etc., and a CD4 protein that plays a role in capturing foreign proteins.
- TCR T cell receptor
- CD4 protein a CD4 protein that plays a role in capturing foreign proteins.
- Major histocompatibility complex containing a peptide (fragment in which a foreign protein has been decomposed) on the cell surface of dendritic cells, macrophages, T cells, etc. that can present antigen to helper T cells Recognize and recognize the body MHC class II (two) molecule.
- helper T cells are divided and activated, and B cells (B lymphocytes) produce antibodies, which are humoral immunity, and killer T cells cause cytotoxicity. To assist efficiently.
- Killer T cells utilize the T cell receptor TCR and the CD8 protein on the surface of killer T cells themselves to produce peptides of antigen molecules on the cell surface of all somatic cells other than red blood cells. Recognizes the MHC class I (one) molecule, which is a major histocompatibility complex incorporated.
- the cell immunity is said to divide and activate and kill cells as killer T cells, and kill and eliminate cells infected with viruses as foreign substances. Plays a central role in the reaction.
- the range of safe body temperature that does not endanger the life of the living body will be given briefly.
- a normal body temperature of 37 degrees is a plus minus 5 degrees range is a safe body temperature range.
- the safe temperature range is between 32 degrees and 42 degrees. If the human body temperature range deviates from the above range, there is a danger to life.
- FIG. 2 is an example of a functional block diagram of the first embodiment.
- the living body hyperthermia treatment device 0200 has a living body storage unit 0201, an anesthesia unit 0202, and a liquid supply unit 0203.
- the “living part” can store living bodies and can be filled with a liquid whose temperature can be controlled.
- “Living organism” refers to the body of a mammalian organism. For example, it may be an animal body, It may be a human body.
- “Storable” means that all parts of the living body can be accommodated in the living body storage part. All parts include the head, neck, torso, arms, hands, thighs, and feet.
- the whole body part may be stored in the living body storage part, or a part of the body may be stored in the living body storage part. For example, a part other than the head of the living body may be housed in the living body storage part.
- “Temperature-controllable liquid” refers to a heating and cooling medium that is a liquid.
- a pouring opening for pouring a temperature-controllable liquid into the living body storage section may be provided downward so that a water flow does not directly hit the living body. Further, the water flow from the pouring port may be changed to a jet water flow to agitate the liquid in the living body storage unit.
- the “anesthesia unit” anesthetizes the living body stored in the living body storage unit.
- it may be an anesthesia machine.
- “Anesthesia” includes local anesthesia, intravenous anesthesia, spinal anesthesia, epidural anesthesia, and general anesthesia.
- the anesthesia unit may use general anesthesia.
- General anesthesia means that the anesthesia gas is mixed with the exhalation of the living body and the living body loses consciousness by inhaling the anesthetic gas into the living body.
- Anesthesia gas may be laughter, halothane, enflurene, ether, etc. By giving the body anesthesia, the body can escape the pain associated with the rise in body temperature.
- anesthetizing the living body may limit the function of the living body.
- the “liquid supply section” supplies the liquid into the living body storage section, and immerses a living body in the liquid.
- the liquid may be stored in the liquid supply unit.
- “Supply” refers to supplying the liquid into the living body storage unit using a water tube or the like.
- the water tube may be provided with pulp. Further, the amount of water supplied by the valve may be adjusted.
- the valve may be provided with a mechanism for controlling opening and closing of the valve.
- “Immersion” refers to immersing a living body in the liquid filled in the living body housing.
- the liquid supply unit includes liquid temperature control means for controlling the temperature of the liquid filled in the living body storage unit.
- the “liquid temperature control means” controls the temperature of the liquid filled in the living body storage part.
- “Temperature system” means, for example, issuing an instruction such as a heating or cooling time and a total amount of heat to the liquid temperature control means based on temperature information from a sensor provided in the living body storage section, Inducing the temperature of the liquid filled in the section to the target temperature.
- FIG. 3 is an example of a schematic diagram showing the entire configuration of the first embodiment.
- the living body thermotherapy device according to the present embodiment includes an adjustment tank 1, a high-temperature tank 2, a low-temperature tank 3, a mixing tank 4, a living-body storage unit (thermal capsule) 5, a discharge unit 6, a suction unit 7, A control computer 8 as liquid temperature control means.
- the temperature information detected by the heat sensors la, 2a, 3a, and 4a is sent to the control computer 8.
- the operations of the electric heaters 1b, 2b, 3b, and 4b and the agitators 1c, 2c, 3c, and 4c are controlled by a control computer 8, which is liquid temperature control means.
- the adjusting tank 1, the high-temperature tank 2, the low-temperature tank 3, and the mixing tank 4 each have a capacity of about 250 to 300 liters.
- the concentration of the Ringer solution is adjusted by adjusting the valves 9 and 10 to mix the Ringer solution and purified water at a predetermined mixing ratio.
- the adjustment tank 1 is controlled by the control computer 8 so that the Ringer's solution in the adjustment tank 1 becomes a predetermined temperature (for example, 37 degrees).
- a high temperature tank 2 and a low temperature tank 3 are connected to the adjustment tank 1 via flow control valves 11 and 12, respectively.
- the high-temperature tank 2 is controlled by the control computer 8 so that the Ringer solution in the high-temperature tank 2 has a predetermined temperature (for example, 43 degrees).
- the low-temperature tank 3 is controlled by the control computer 8 so that the Ringer's solution in the low-temperature tank 3 has a predetermined low temperature (for example, 37 degrees).
- the operation of the flow control valves 11 and 12 is controlled by a control signal from the control computer 8. Is controlled.
- a mixing tank 4 is connected to the high temperature tank 2 and the low temperature tank 3.
- a flow control valve 13 is provided between the high temperature tank 2 and the mixing tank 4, and a flow control valve 14 is provided between the low temperature tank 3 and the mixing tank 4.
- the mixing tank 4 mixes the Ringer solution in the high-temperature tank 2 and the Ringer solution in the low-temperature tank 3 to form a Ringer solution at a predetermined temperature.
- the mixing tank 4 is controlled by the control computer 8 so that the Ringer's solution in the mixing tank 4 is maintained at a predetermined temperature.
- the operation of the flow control valves 13 and 14 is controlled by a control signal of the control computer 8.
- the living body storage unit (thermal capsule) 5 is connected to the mixing tank 4 via a water supply valve 15. The operation of the water supply valve 15 is controlled by a control signal from a control computer 8.
- the living body storage section (thermal capsule) 5, which is a living body storage section, can be filled with a Ringer solution of about 250 liters.
- the living body storage unit (thermal capsule) 5 serving as a living body storage unit includes a lid 5a, a heat sensor 5b for detecting the temperature of the Ringer solution in the living body storage unit (heat capsule) 5, and a living body storage unit.
- a stirrer 5c for stirring the Ringer's solution in the storage part (heat capsule) 5 is included.
- Information on the temperature of the Ringer's solution detected by the thermal sensor 5b is sent to the control computer 8.
- the operation of the stirrer 5 c is controlled by a control signal from the control computer 8.
- the living body storage section (thermal capsule) 5 is formed so as to include a material having a low thermal conductivity and a high heat retaining effect.
- the living body storage part (thermal capsule) 5 is formed by a structure in which FRP (fiber reinforced plastic) is double-layered and filled with a heat insulating material such as foamed polyurethane.
- a discharge unit 6 for discharging the Ringer's solution from the mixing tank 4 into the biological storage unit (thermal capsule) 5 and a biological storage unit (thermal capsule) are provided inside the biological storage unit (thermal capsule) 5.
- a suction section 7 for draining the Ringer solution in 5 to the outside is provided. Vomit The outlet 6 has a plurality of discharge ports.
- the control computer 8 which is a liquid temperature control means, controls the adjusting tank 1, which is a liquid supply unit, so that the temperature of the Ringer solution in the living body storage unit (thermal capsule) 5 becomes a predetermined treatment temperature. Controls the operation of high-temperature tank 2, low-temperature tank 3, mixing tank 4, flow control valves 11 to 14 and water supply valve 15. That is, the control computer 8 adjusts the adjusting tank 1, the high-temperature tank 2, the low-temperature tank 3, the mixing tank 4, and the flow control valve 11 based on the temperature information of the Ringer's solution in the living body storage section (thermal capsule) 5. By controlling the operations of the water supply valve 14 and the water supply valve 15, feedback control is performed so that the temperature of the Ringer's solution in the living body storage unit (thermoelectric force cell) 5 becomes a predetermined treatment temperature.
- a predetermined treatment temperature is set in the control computer 8.
- the control computer 8 adjusts the adjusting tank 1, the high-temperature tank 2, the low-temperature tank 3, and the mixing tank so that the temperature of the Ringer's solution filled in the biological storage unit (thermal capsule) 5 becomes the set treatment temperature.
- the prescribed treatment temperature is initially set at 37 ° C and is raised about once a hour. However, the prescribed treatment temperature should be set within the range of 37 degrees to 43 degrees. This is to prevent the death of normal cells by setting the predetermined treatment temperature lower than the normal cell death temperature of 43 degrees.
- the control computer 8 controls the electric heater 1 b and the stirrer 1 c in the adjustment tank 1 based on the temperature information from the heat sensor 1 a in the adjustment tank 1, thereby controlling the ringer in the adjustment tank 1. Control the temperature of the solution to a predetermined temperature (for example, 37 degrees).
- the flow control valves 11 and 12 are controlled based on control signals from the control computer 8. Then, the Ringer's solution in the adjustment tank 1 is supplied to the high temperature tank 2 and the low temperature tank 3 by a predetermined amount, respectively.
- the control computer 8 controls the electric heater 3 b and the stirring device 3 c in the high-temperature tank 2 based on the temperature information from the heat sensor 2 a in the high-temperature tank 2, thereby controlling the temperature in the high-temperature tank 2. Control so that the Ringer's solution has a predetermined high temperature (for example, 43 degrees).
- the control computer 8 controls the electric heater 3 b and the stirrer 3 c in the low-temperature tank 3 based on the temperature information from the heat sensor 3 a in the low-temperature tank 3 to control the temperature in the low-temperature tank 3. Control the temperature of the Ringer's solution to a predetermined low temperature (for example, 37 degrees).
- the operation of the flow control valves 13 and 14 is controlled based on a control signal from the control computer 8 so that the Ringer solution in the high temperature tank 2 and the Ringer solution in the low temperature tank 3 are mixed at a predetermined mixing ratio. It is supplied to the mixing tank 4. Thus, a Ringer solution having a predetermined temperature is created in the mixing tank 4. Further, the control computer 8 controls the electric heater 4 b and the stirrer 4 c in the mixing tank 3 based on the temperature information from the heat sensor 4 a in the mixing tank 4, thereby controlling the temperature in the mixing tank 3. Control so that the Ringer's solution is maintained at a predetermined temperature.
- the operation of the water supply valve 15 is controlled based on a control signal from the control computer 8, and a predetermined amount of Ringer's solution having a predetermined temperature is supplied from the mixing tank 4 to the discharge section 6 of the living body storage section (thermal capsule) 5. You. As a result, the Ringer solution having a predetermined temperature is discharged from the plurality of discharge ports of the discharge header 6. By discharging the Ringer's solution from the plurality of discharge ports in this manner, the temperature of the Ringer's solution in the living body storage unit (thermal capsule) 5 can be made more uniform than when discharging the Ringer's solution from a single location.
- the Ringer's solution in the living body storage section (thermal capsule) 5 is stirred by the stirrer 5 c based on a control signal from the control computer 8. As a result, the temperature of the Ringer's solution in the living body storage section (thermal capsule) 5 can be further uniformed.
- general anesthesia is applied to the living body through the anesthesia section.
- the body temperature control function of the human body is reduced, and the whole body temperature may become almost the same as the environmental temperature (the temperature of the Ringer solution in the living body storage unit 5). .
- the body temperature of the human body can be easily adjusted. As a result, the body temperature of the human body can be easily controlled to a predetermined treatment temperature.
- cancer cells and viruses in all parts of the living body except for the head can be killed.
- the living body is maintained at the target temperature for a predetermined time required for treatment, and by activating leukocytes of the living body, cancer cells and viruses in the living body are strongly killed. Can be done.
- the liquid temperature control means of the liquid supply unit of the living body thermal treatment apparatus controls the rate of temperature rise of the liquid filled in the living body storage unit.
- the liquid temperature control means of the living body thermotherapy device can raise the temperature of the liquid in which the living body is immersed at an increasing rate that maintains the parasympathetic nerve superiority of the living body.
- the “parasympathetic nervous system” is one of the two autonomic nervous systems, the sympathetic nervous system and the parasympathetic nervous system, in which the functions of the body are governed.
- the ratio of granulocytes to lymphocytes is regulated by the autonomic nervous system of the granulocytes and lymphocytes in the leukocytes of the blood of the living body.
- the “parasympathetic dominance” means that the granulocytes are obtained by regulating the body of the living body of the parasympathetic nervous system.
- the ratio of lymphocytes is higher than the ratio of granulocytes. There is also an effect that blood flow improves when the body of the living body has a superior parasympathetic advantage.
- “Maintenance” means that the state of the lymphocyte leukocytes in the blood is higher than the granulocyte ratio due to the regulation of the parasympathetic nerve in the autonomous nervous system of the living body.
- the “rise rate” refers to a temperature increase per unit time when increasing the temperature of the liquid for immersing the living body filled in the living body housing part. For example, the unit time is 1 degree in 10 minutes, and the rate of increase when the temperature of the liquid is increased is 1/10 (degrees / minute).
- “Temperature increase” refers to increasing the temperature of the liquid in the living body storage part.
- the rate of increase in the temperature of the liquid when the liquid temperature control means of the living body hyperthermia device raises the temperature of the liquid in which the living body is immersed is determined by changing the temperature of the liquid from the normal body temperature of the living body to 38 degrees Celsius.
- the time for raising the temperature of the liquid is not less than 5 minutes, and the time for raising the temperature of the liquid from 38 degrees Celsius to 39 degrees Celsius is not less than 10 minutes.
- Normal body temperature is the normal body temperature of the living body.
- “Time to raise” refers to the time required for the body temperature of the living body to reach a predetermined temperature.
- “5 minutes or more” means that the time required for the body temperature of the living body to reach 38 ° C. from the normal temperature is 5 minutes or more.
- “10 minutes or more” means that the time required for the body temperature of the living body to reach a temperature of 38 ° C. to 39 ° C. is 10 minutes or more.
- FIG. 4 shows an example of data when the rectal temperature of the living body stored in the living body storage section of the living body thermotherapy device changes due to the temperature control of the liquid temperature control means.
- “Hot water” in the event column in FIG. 4 is when the living body is immersed in the liquid in the living body storage unit.
- the “hot water” in the event column in FIG. 4 is when the living body comes out of the living body storage unit.
- the time required for the body temperature of the living body to reach 38 degrees from the normal temperature is 10 minutes, and the time required for the body temperature to reach 38 degrees to 39 degrees is 11 minutes. It is.
- Fig. 5 shows an example of data comparing the proportion of lymphocyte subsets in a living body in blood collection just before bathing and immediately after bathing.
- CD4 is a marker possessed by helper T cells, which are a subset of lymphocytes in living blood.
- CD8 is also a lymphocyte subset, killer T cells and suppressors There are markerers that T cells have. Measuring two markers, CD4 and CD8, in the examination of blood in vivo The percentage of lymphocyte subsets was determined.
- Immediately before bathing is immediately before the living body is immersed in the liquid in the living body storage section.
- Immediately after tapping is the time immediately after the living body comes out of the living body storage unit and is no longer immersed in liquid.
- the ratio of CD 4 immediately after tapping exceeds the reference value, and it is determined that the ratio of CD 4 has increased. This is an example of data indicating that subsympathy is superior when a living body is immersed in the liquid.
- the rate of increase in the temperature of the liquid when the liquid temperature control means of the living body thermotherapy device raises the temperature of the liquid that immerses the living body is determined by changing the temperature of the liquid from the normal body temperature of the living body to Celsius.
- the time for raising the temperature to 38 degrees is 5 minutes or more
- the time for raising the temperature of the liquid from 38 degrees Celsius to 39 degrees Celsius is 10 minutes or more
- the temperature of the liquid is 39 degrees Celsius
- the time to increase from 40 degrees to 41 degrees Celsius is 15 minutes or more. “15 minutes or more” means that the time required for the body temperature of the living body to reach a temperature of 39 ° C. to 41 ° C. is 15 minutes or more.
- the rate of increase in the temperature of the liquid when the temperature of the liquid in which the living body is immersed is increased by the liquid temperature control means of the living body hyperthermia treatment device is defined as the temperature of the liquid from the normal body temperature of the living body.
- the time for raising the temperature to 38 degrees is 5 minutes or more, and the time for raising the temperature of the liquid from 38 degrees Celsius to 39 degrees Celsius is 10 minutes or more, and the temperature of the liquid is 39 degrees Celsius
- the time required to increase the temperature of the liquid from 41 degrees Celsius to 42 degrees Celsius is 20 minutes or more. “20 minutes or more” means that the time required for the body temperature of the living body to reach a temperature of 41 ° C. from 42 ° C. is 20 minutes or more.
- the liquid temperature control means for controlling the temperature of the liquid filled in the living body storage section, which is included in the liquid supply section of the living body thermotherapy device, is configured to maintain the temperature of the liquid at a level that maintains the parasympathetic nerve superiority of the living body.
- the temperature rises at the rate of increase.
- the rate of increase at that time may be 5 minutes or more for the time for raising the temperature of the liquid from the normal body temperature of the living body to 38 degrees Celsius.
- the time for raising the temperature of the liquid from 38 degrees Celsius to 39 degrees Celsius may be 10 minutes or more.
- the time for raising the temperature of the liquid from 39 degrees Celsius to 41 degrees Celsius may be 15 minutes or more.
- the time for raising the temperature of the liquid from 41 degrees Celsius to 42 degrees Celsius may be 20 minutes or more.
- the liquid temperature control means of the liquid supply unit of the living body hyperthermia device controls the rate of increase in the temperature of the liquid filled in the living body storage unit at the rate of increase described in the present embodiment, whereby the white blood cells of the living body are treated. When activated, it can strongly kill cancer cells and viruses in the living body.
- the living body is maintained at the target temperature for a predetermined time required for treatment, and by activating leukocytes of the living body, cancer cells and viruses in the living body are strongly killed. Can be done.
- the liquid temperature control means of the night body supply unit of the living body heat treatment apparatus controls the temperature of the liquid filled in the living body storage unit, and After guiding the temperature to the target temperature, the liquid temperature control means controls the temperature of the liquid such that the deep body temperature is maintained at the target temperature for a predetermined time for producing a therapeutic effect.
- the lymphocyte superiority of the living body is maintained.
- the liquid temperature control means of the living body hyperthermia treatment device can perform control for maintaining the deep body temperature of the living body at a target temperature between 40 and 42 degrees Celsius for a predetermined time.
- “Deep body temperature” refers to the temperature inside the body of a living body. For example, it may be the rectal temperature of a living body.
- “Target temperature” means a temperature between 40 and 42 degrees Celsius. For example, the temperature at which cancer cells are killed.
- the “predetermined time” is the time required for treating a disease of a living body. For example, it may be a time required to kill all cancer cells and the like in a living body.
- “Maintaining” means maintaining the state in which the temperature inside the body of the living body is raised to the target temperature.
- Control means that the temperature of the liquid filled in the living body storage unit is induced by the liquid temperature control unit to maintain the temperature of the liquid at a target temperature. This is made possible by the liquid temperature control means described in the first embodiment.
- the liquid temperature control means of the living body hyperthermia device maintains the deep body temperature of the living body at a target temperature between 40 degrees Celsius and 42 degrees Celsius for 15 minutes or more and 7 hours or more.
- Control. "15 minutes or more and 7 hours or less” means that the time for maintaining the temperature inside the body of the living body at the target temperature between 40 degrees Celsius and 42 degrees Celsius is 15 minutes or more and 7 hours or less. Is limited. This is because if the temperature inside the body reaches the target temperature within 15 minutes, the body becomes dominant in the sympathetic nervous system. Further, if the living body is maintained at the target temperature for 7 hours or more, there is a danger to life.
- the liquid temperature control means of the living body hyperthermia device the liquid temperature control means for raising the deep body temperature of the living body from the normal body temperature of the living body to the target temperature within 5 to 60 minutes
- the body temperature can be raised from 36.5 degrees centigrade plus or minus 1 degree to the target temperature within 3 to 55 minutes.
- “Within 5 minutes to 60 minutes” means that the time required to reach the target temperature from the normal body temperature of the living body to the target temperature is within 5 minutes to 60 minutes. It was done.
- “36.5 degrees centigrade plus or minus 1 degree” means that the temperature of the liquid before the temperature is raised is 36.5 degrees centigrade plus or minus 1 degree.
- “3 minutes to 55 minutes” means that the time required to raise the temperature of the liquid and reach the target temperature is within 3 minutes to 55 minutes. "The temperature can be raised” It means that the temperature of the liquid can be raised to a target temperature. This is made possible by the liquid temperature control means described in the first embodiment.
- the liquid temperature control means of the living body hyperthermia device the temperature of the deep part of the body of the living body is raised from the normal body temperature of the living body to the target temperature within 10 to 40 minutes,
- the temperature of the liquid can be raised from 36.5 degrees centigrade plus or minus 1 degree to the target temperature in 7 to 36 minutes.
- “Within 10 to 40 minutes” means that the time required for the temperature of the liquid to rise and the temperature inside the body of the living body to reach the target temperature is within 10 to 40 minutes. It is limited. “Within the time of 10 minutes to 40 minutes” is an optimal target time more than the above “within the time of 5 minutes to 60 minutes”.
- the living body When the temperature inside the body of the living body reaches the target temperature from the normal body temperature of the living body to the target temperature within 10 minutes, the living body becomes dominant in the sympathetic nerve, and thus is limited to “from 10 minutes”.
- the reason why the time is limited to “within 40 minutes” is that a load is applied to a living body when the time exceeds 40 minutes. “Within 7 minutes to 36 minutes” means that the time required to raise the temperature of the liquid and reach the target temperature is within 7 minutes to 36 minutes.
- the liquid control means of the living body thermotherapy device controls the temperature of the liquid in units of 0.1 degree Celsius.
- the unit of 0.1 degree Celsius means that the liquid control means can set a target temperature in units of 0.1 degree Celsius, and can raise or lower the temperature of the liquid in units of 0.1 degree.
- the liquid temperature control means is capable of performing control for maintaining the temperature inside the body of the living body at a target temperature which is a temperature between 40 degrees Celsius and 42 degrees Celsius for a predetermined time. At this time, the liquid temperature control means may maintain the temperature inside the body of the living body at a target temperature between 40 degrees Celsius and 42 degrees Celsius for 15 minutes or more and 7 hours or less. Further, in order to raise the temperature inside the body of the living body from the normal body temperature of the living body to the target temperature within a period of 5 to 60 minutes, the temperature of the liquid is set to 36.5 degrees Celsius plus or minus 1 degree. The temperature may be raised to the target temperature within a time period of 3 to 55 minutes.
- the temperature of the liquid is raised from 36.5 degrees centigrade plus or minus 1 degree.
- the target temperature may be raised within 7 to 36 minutes.
- the liquid temperature control means of the liquid supply unit of the living body thermotherapy device controls the temperature of the liquid filled in the living body storage unit so that the living body is maintained at the target temperature for a predetermined time, thereby activating leukocytes.
- the living body is kept in a state of dominant lymphocytes, thereby strongly killing cancer cells and viruses in the living body. be able to.
- the living body is maintained at the target temperature for a predetermined time required for treatment, thereby activating leukocytes of the living body, and a liquid after the living body is immersed in the living body housing part. Even when the living body is not immersed in the living body, the living body is maintained in a state of being predominantly lymphocyte, so that cancer cells and viruses in the living body can be strongly killed.
- FIG. 6 shows an example of a functional block diagram of the fourth embodiment.
- the living body thermotherapy device is capable of storing a living body and can be filled with a temperature-controllable liquid therein, an anesthesia unit for performing anesthesia on the living body stored in the living body storage section, and the liquid
- a liquid supply unit for supplying a liquid to the living body storage unit and immersing a living body in the liquid; and a liquid temperature control unit for controlling the temperature of the liquid filled in the living body storage unit provided in the liquid supply unit.
- the living body temperature is raised from the normal body temperature of the living body to the target temperature within 5 to 60 minutes by the liquid temperature control means.
- the ratio of granulocytes and lymphocytes of the leukocytes of the living body is adjusted to be superior to lymphocytes.
- the ratio of granulocytes to lymphocytes in white blood cells The percentage of granulocytes and leukocytes in leukocytes and the percentage of lymphocytes in leukocytes.
- Lymphocyte dominance refers to a state in which the proportion of lymphocytes is greater than the proportion of granulocytes in the proportion of granulocytes and lymphocytes of the white blood cells.
- Adjustment refers to inducing the body of the living body to the above-described lymphocyte-dominant state in leukocytes of the blood of the living body.
- FIG. 7 shows an example of data indicating that the granulocyte count does not change immediately before the bathing of the living body and immediately after the bathing.
- the bathing time of the living body is about 20 minutes, and the living body is not anesthetized.
- “Immediately” in FIG. 7 to FIG. 10 is immediately after the living body exits the living body storage unit after being immersed in the liquid in the living body storage unit.
- “Before” in FIGS. 7 to 10 is immediately before the living body is immersed in the living body storage unit.
- FIGS. 7 to 10 are tables showing whether or not there is a significant difference between the value of the white blood cell component immediately after the living body and the value of the immediately preceding white blood cell component.
- the average number of granulocytes immediately after tapping is 38.42.92.98577-1.
- the average number of condyle spheres immediately before bathing is 3 861.6.67 785771.
- the number of observations is 28 immediately after bathing and immediately before bathing. Since the absolute value of “t” is smaller than the value of “t boundary value both sides”, it shows that there is no difference in the average number between a pair of samples immediately after bathing and immediately before bathing. In other words, it can be said that there is no significant difference in the risk factor of 5% or less between the immediately preceding and immediately following granulocyte counts.
- FIG. 8 shows an example of data indicating an increase in the number of lymphocytes when a living body was compared before and after bathing.
- the average number of lymphocytes immediately after tapping is 2712.5.
- the average number of lymphocytes immediately before bathing is 2258.75.
- the number of observations is 28 immediately after bathing and immediately before bathing. Since the absolute value of “t” is larger than the value of “t boundary value both sides”, it indicates that there is a difference in the average number between a pair of samples immediately after bathing and immediately before bathing. In other words, it can be said that there is a significant difference between the lymphocyte count immediately before and immediately after the above with a risk factor of 5% or less.
- FIG. 9 and FIG. 10 show examples of data indicating an increase in the number of lymphocytes and lymphocyte subsets when a living body was compared before and after bathing.
- CD3 is a marker for T cells.
- CD4 is a marker for helper T cells and is a subset of T lymphocytes. A subset is a child set.
- the average number of CD 3 immediately before bathing is 1 415.
- the average number of CD 3 immediately after tapping is 1.710.
- the number of observations is 20 immediately after bathing and immediately before bathing. Since the absolute value of “t” is larger than the value of “t boundary value both sides”, it indicates that there is a difference in the average number between a pair of samples immediately after bathing and immediately before bathing. In other words, it can be said that there is a significant difference in the T lymphocyte count between immediately before and immediately after the above with a risk factor of 5% or less.
- CD4 is a marker for helper T cells and is a subset of CD3. A subset is a child set. According to FIG. 10, the average number of CD 4 immediately before bathing is 810. The average number of CD 4 immediately after tapping is 10 15. The number of observations is 20 immediately after bathing and immediately before bathing. Since the absolute value of “t” is larger than the value of “t boundary value both sides”, it indicates that there is a difference in the average number between a pair of samples immediately after bathing and immediately before bathing. In other words, it can be said that there is a significant difference in the number of T lymphocyte subset cells between the immediately preceding and the immediately following at a risk factor of 5% or less.
- the liquid filled in the living body storage part is 40 degrees or more, and the living body is immersed in the liquid for 15 to 20 minutes.
- helper T cells increase at a rate of 20 to 30% when the body temperature of the living body exceeds 39 degrees.
- FIG. 7 also shows that the number of granulocytes does not change at all or slightly decreases. This means that the activation of the lymphocyte system controlled by the parasympathetic nerve in the autonomic nervous system of the living body can be induced by heating the living body by the living body thermotherapy device. It is shown that the induction of lymphocyte activation alone can improve the immune status of granulocyte-dominant cancer patients and AIDS patients.
- the living body thermotherapy device is capable of storing a living body in an immunodeficient state, and a living body storage part capable of being filled with a temperature-controllable liquid therein; and a living body stored in the living body storage part.
- An anesthesia unit for performing anesthesia; supplying the liquid into the living body storage unit;
- a liquid supply unit for immersion in the liquid;
- liquid temperature control means for controlling the temperature of the liquid filled in the living body storage unit provided in the liquid supply unit.
- Immuno deficiency state refers to a state in which the body has no immune response.
- the phrase “within 8 to 47 minutes” limits the time required for the living body to reach the target temperature by raising the temperature of the liquid within 8 to 47 minutes.
- “15 minutes to 3 hours” means that the time required to maintain the temperature inside the body of the living body at a target temperature between 40 degrees Celsius and 42 degrees Celsius is 15 minutes to 3 hours. It is specified.
- “Sound immune state” refers to a state in which an immune response exists in a living body.
- the living body thermotherapy device has a living body state measuring unit for measuring a state of the living body stored in the living body storage unit, and the liquid temperature control unit performs measurement on the measurement result of the living body state measuring unit.
- the “biological state measuring unit” measures the state of the living body stored in the living body storing unit.
- the “measurement result” is a result of measuring the deep temperature of a living body by the living body condition measuring unit.
- Controllable means that the liquid temperature control means of the living body storage unit can raise or lower the temperature of the liquid until the deep part temperature of the living body reaches the target temperature based on the measurement result of the living body condition measuring unit. .
- feedback control may be used.
- FIG. 11 is an example of a schematic diagram showing the configuration of the living body storage section 110 of the fourth embodiment.
- the living body is immersed in a liquid whose temperature can be controlled in the living body storage part of the fourth embodiment.
- a part other than the head of the living body is immersed in the liquid.
- the living body sucks anesthesia gas 1101 from the anesthesia unit.
- Electrodes may be provided on the fingertips and toes of the living body's hands to measure electrocardiogram data and the like.
- a rectal thermometer may be inserted into the anus of the living body to measure rectal temperature.
- the head of the living body is on the liquid surface 1 1 0 2 It is supported by instruments to become.
- the “liquid surface” is a surface that distinguishes a liquid and a gas in the living body storage unit.
- the height of the liquid level may be adjusted by the liquid supply unit.
- the “adjustment” may be, for example, measuring the height of the liquid surface using a water level sensor and adjusting the amount of liquid supplied to the living body storage unit.
- the liquid is represented as hot water.
- the hot water is supplied into the living body storage unit by a plurality of discharge units (hot water outlets) 110 3.
- the presence of the plurality of ejection sections can prevent the temperature of the liquid at a specific location in the living body storage section from increasing.
- the discharge unit is provided so that the hot water is supplied downward.
- the warm water is supplied downward into the living body housing, so that the flow of the warm water is not directly applied to the living body, and it is possible to prevent a specific portion of the living body from rapidly rising in temperature.
- the hot water is constantly supplied to the living body storage unit by the discharge unit. Then, the water is constantly drained from a drain port provided in the living body storage unit.
- the “drain port” is a port for discharging the liquid provided in the living body storage unit.
- the outlet may be provided with a valve or a pump for adjusting the amount of drainage. Water may be drained so that the height of the liquid surface does not change.
- the system in which the hot water is drained after being supplied into the living body housing is called a forced circulation system.
- FIG. 12 is a diagram showing an example of experimental data and a diagram showing a temperature distribution of a liquid filled in the living body storage part together with the configuration of the living body storage part of the fourth embodiment.
- the plurality of ejection units are provided at three positions on the left and right sides provided on the side surface of the living body storage unit below the position of the living body in the living body storage unit.
- (1) in Fig. 12 shows the temperature distribution of the liquid filled in the living body storage unit.
- the part of the living body storage part filled with the liquid is called a treatment tank.
- the longitudinal length of the treatment tank is 720 mm and the lateral length is 1925 mm.
- the positions of the measurement points are measurement points 1 to 12, which are the positions shown in Fig. 12 (1).
- the measurement points from measurement points 1 to 12 have two measurement points above and below.
- the measurement points from measurement points 13 to 15 are only above. Therefore, the total measurement points of the treatment tank are 27 points.
- “Head side” means the side on which the head of a living body is placed.
- “Measurement temperature” is the temperature measured by the temperature sensor. Each total The measurement temperature at the measurement point is described.
- FIG. 12 (2) is a cross-sectional view of a to a in FIG. 12 (1). According to FIG. 12 (2), the height of the treatment tank is 51 O mm. The liquid level is 5 O mm below the upper part of the treatment tank.
- “Stretcher” is a device that supports the body of a living body.
- “Liquid level” refers to the liquid level.
- the “upper measurement point” is the upper measurement point of the upper and lower two points that the measurement points from measurement points 1 to 12 have.
- the “lower measurement point” is the lower measurement point of the two upper and lower points of the measurement points 1 to 12.
- (3) in Fig. 12 is a table analyzing the results of measuring the temperature of the liquid.
- the “treatment tank volume” in (12) in FIG. 12 is the total volume of the liquid filled in the treatment tank.
- “Treatment tank set temperature” is the target temperature of the liquid in the treatment tank.
- the “room temperature” is the temperature of the atmosphere in the room where the living body storage unit is placed.
- the “maximum temperature” is the highest temperature of the liquid in the treatment tank measured by the temperature sensor at the measurement point 27 in the treatment tank.
- the “minimum temperature” is the lowest temperature of the liquid in the treatment tank measured by the temperature sensor at the measurement point 27 in the treatment tank.
- “Average temperature” is the average temperature of the liquid measured by the temperature sensor at 27 measurement points in the treatment tank.
- Standard deviation is the standard deviation of the temperature of the liquid measured by the temperature sensor at 27 measurement points in the treatment tank. According to FIG. 12 (3), when the treatment tank set temperature is 42 degrees, the maximum temperature of the liquid in the treatment tank is 42 degrees and the minimum temperature is 41.998 degrees. It can be seen that there is only a temperature variation within 0.02 degrees within the liquid in the treatment vessel.
- the temperature of the liquid seen in the living body housing is kept in a range of minus 0.02 degrees from the target temperature.
- the temperature control can be performed in units of 0.1 degrees, so that it is understood that the living body hyperthermia treatment device according to the present invention can be sufficiently used for hyperthermia treatment.
- the liquid and the liquid are controlled. Synchronization of the temperature of the living body can be realized, and hyperthermia can be performed on the living body.
- FIG. 13 is an example of a schematic diagram showing the entire configuration of the fourth embodiment.
- the explanation Pj of the part overlapping the first embodiment is omitted.
- a characteristic part of the present embodiment is a biological condition measuring unit.
- a rectal thermometer is installed in the living body.
- the liquid temperature control means raises or lowers the temperature of the liquid stored in the liquid supply unit so that the value of the rectal thermometer becomes the target temperature, and supplies the raised or lowered liquid to the living body storage unit. This raises or lowers the temperature of the liquid filled in the living body housing. Then, the temperature of the living body rises or falls through the liquid filled in the living body storage section.
- the liquid temperature control means performs feedback control so that the temperature of the living body becomes the target value. Cooling means that the temperature of the liquid drops.
- the liquid temperature control means of the liquid supply unit of the living body hyperthermia treatment device controls the temperature of the liquid filled in the living body storage unit so that the living body is maintained at the target temperature for a predetermined time, whereby the white blood cells of the living body are obtained. And to adjust the ratio of granulocytes and lymphocytes of the leukocytes to lymphocytes predominantly even if the living body is not immersed in a liquid after being immersed in the living body storage part. Thus, cancer cells and viruses in the living body can be strongly killed.
- the present invention almost the whole body of a living body can be treated by hyperthermia.
- a therapeutic effect can be obtained even when the state of metastasis of cancer cells is unknown.
- the body temperature of the living body can be adjusted with high accuracy.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004522702A JPWO2004009003A1 (ja) | 2002-07-22 | 2002-07-22 | 生体温熱治療装置 |
PCT/JP2002/007390 WO2004009003A1 (ja) | 2002-07-22 | 2002-07-22 | 生体温熱治療装置 |
AU2002318613A AU2002318613A1 (en) | 2002-07-22 | 2002-07-22 | Thermotherapy system for organism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2002/007390 WO2004009003A1 (ja) | 2002-07-22 | 2002-07-22 | 生体温熱治療装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004009003A1 true WO2004009003A1 (ja) | 2004-01-29 |
Family
ID=30490766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/007390 WO2004009003A1 (ja) | 2002-07-22 | 2002-07-22 | 生体温熱治療装置 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2004009003A1 (ja) |
AU (1) | AU2002318613A1 (ja) |
WO (1) | WO2004009003A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005110298A1 (ja) * | 2004-05-19 | 2008-03-21 | 株式会社 サーモビジョン | 酸化還元電位に基づく温熱治療システム |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5937108B2 (ja) * | 1982-10-12 | 1984-09-07 | インタ−・ノバ株式会社 | 全身温熱加温装置 |
JPH1033626A (ja) * | 1996-07-19 | 1998-02-10 | Shinji Miyazaki | 温浴型温熱治療装置 |
WO2001080789A1 (fr) * | 2000-04-24 | 2001-11-01 | Thermedix Co.,Ltd. | Dispositif de thermotherapie |
-
2002
- 2002-07-22 JP JP2004522702A patent/JPWO2004009003A1/ja active Pending
- 2002-07-22 AU AU2002318613A patent/AU2002318613A1/en not_active Abandoned
- 2002-07-22 WO PCT/JP2002/007390 patent/WO2004009003A1/ja active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5937108B2 (ja) * | 1982-10-12 | 1984-09-07 | インタ−・ノバ株式会社 | 全身温熱加温装置 |
JPH1033626A (ja) * | 1996-07-19 | 1998-02-10 | Shinji Miyazaki | 温浴型温熱治療装置 |
WO2001080789A1 (fr) * | 2000-04-24 | 2001-11-01 | Thermedix Co.,Ltd. | Dispositif de thermotherapie |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005110298A1 (ja) * | 2004-05-19 | 2008-03-21 | 株式会社 サーモビジョン | 酸化還元電位に基づく温熱治療システム |
Also Published As
Publication number | Publication date |
---|---|
JPWO2004009003A1 (ja) | 2005-11-17 |
AU2002318613A1 (en) | 2004-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080255637A1 (en) | Thermotherapy System Based on Redox Potential | |
US6620130B1 (en) | Infusion systems and methods for introducing fluids into the body within a desired temperature range | |
US3821947A (en) | Infant warmer-incubator | |
EP2815781A1 (en) | Anti-explosion gas generator for health use | |
US20080097561A1 (en) | Dual cycle thermal system and method of use | |
Horsman et al. | Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation | |
CN108289702A (zh) | 用于向大脑和脊髓提供局灶性冷却的装置和方法 | |
Robinson et al. | Regulation of granulopoiesis: positive feed-back | |
WO2004009003A1 (ja) | 生体温熱治療装置 | |
HUP9800776A2 (hu) | Eljárás és elrendezés vér online extracorporalis terápiás kezelésére, eljárás és fecskendős szivattyú előre meghatározott koncentrációjú oldat formájú gyógyhatású készítmény online bejuttatására páciens véráramába és eljárás lamináris áramlásban ... | |
CN209645400U (zh) | 阴茎浸泡杯 | |
CA2436472C (en) | Laminate device for the output of chemical/physical parameters | |
KR101968304B1 (ko) | 고주파 암 치료 장치 | |
CN208611315U (zh) | 一种新型泌尿外科熏蒸装置 | |
WO2001080789A1 (fr) | Dispositif de thermotherapie | |
Demling et al. | Method for measurement of blood flow and acidity in the human stomach | |
Moon et al. | A literature review about application of an auricular acupuncture therapy for independent oriental medical nursing intervention development | |
JP2003126213A (ja) | 治療装置 | |
JP2003126135A (ja) | 温熱治療装置 | |
CN219763333U (zh) | 一种骨骼肌收缩水浴试验装置 | |
RU2090163C1 (ru) | Устройство для проведения процедур общей управляемой гипертермии | |
US20040073259A1 (en) | Treatment of patients infected by disease causing organisms or biological warfare agents using hyperthermia | |
US1863533A (en) | Thermal treatment applicator | |
CN117180091A (zh) | 一种妇科疾病治疗用理疗装置 | |
US10293095B2 (en) | Hyperoxygenation/hyperthermia treatment apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2004522702 Country of ref document: JP |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |